Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
NCT04806620 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2026-01-22
Summary
The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle information from individuals with brain inflammation and related neuroinflammatory conditions. Participants in the United States aged 2 years and older will provide self-reported health data, biometrics, and symptom diaries through the MyDataHelps™ app (branded as unhide® for this study). The goal is to create comprehensive longitudinal profiles to facilitate research into disease subtypes, causes, diagnostics, and potential treatments, as well as to identify potential participants for future optional studies. "Healthy" individuals without brain inflammation are also eligible to participate.
The digital health research platform used in this study was originally developed and designed by Solve M.E and was called SolveTogether. The Brain Inflammation Collaborative (BIC) expanded upon Solve M.E.'s work to include related diagnoses, pediatric participants, enhance symptom tracking, and more. BIC and Solve M.E. combined Solve Together and unhide®, to create The unhide® Solve Together Unified Platform in 2025.
Conditions
- Post-Acute COVID-19 Syndrome
- ME/CFS
- Rheumatic Arthritis
- Juvenile Rheumatoid Arthritis (JRA)
- Psoriatic Arthritis (PsA)
- Ankylosing Spondylitis (AS)
- Autoimmune Encephalitis
- Celiac Disease
- Celiac Disease in Children
- Chronic Lyme Disease
- Post-treatment Lyme Disease Syndrome
- Crohn's Disease
- Dysautonomia
- Anorexia Nervosa
- Bulimia Nervosa
- ARFID
- Avoidant / Restrictive Food Intake Disorder
- Ehlers Danlos Syndrome
- Endometriosis
- Fibromyalgia (FM)
- Long COVID
- Lupus
- Migraines
- Mast Cell Activation Syndrome
- Multiple Sclerosis
- Myalgic Encephalomyelitis (ME)
- Myasthenia Gravis, Generalized
- Myasthenia Gravis in Children
- Narcolepsy
- Obsessive Compulsive Disorder (OCD)
- PANDAS
- Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)
- POTS - Postural Orthostatic Tachycardia Syndrome
- General Anxiety Disorder, Social Anxiety Disorder
- PTSD - Post Traumatic Stress Disorder
- Psoriasis
- Traumatic Brain Injury
- Tourette's Syndrome
- Inflammatory Bowel Disease (IBD)
- Autoimmune Diseases
- Neurological Diseases or Conditions
- Psychiatric Disorder
- Sjogren's Syndrome
- Ulcerative Colitis and Crohn's Disease
Sponsors & Collaborators
-
Solve ME/CFS Initiative
collaborator OTHER -
Care Evolution
collaborator UNKNOWN - collaborator OTHER
-
Brain Inflammation Collaborative
lead OTHER
Principal Investigators
-
Megan L Fitzgerald, PhD · Brain Inflammation Collaborative
Eligibility
- Min Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-07-05
- Primary Completion
- 2030-06-30
- Completion
- 2030-12-31
Countries
- United States
Study Locations
More Related Trials
-
Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic
NCT04018222 ·Status: UNKNOWN
-
Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus
NCT00042523 ·Status: COMPLETED
-
Immunome Project Consortium for Autoinflammatory Disorders
NCT03919110 ·Status: COMPLETED
-
New Biomarkers in Auto-immune Encephalitis and Neurological Paraneoplastic Syndromes
NCT05728931 ·Status: ACTIVE_NOT_RECRUITING
-
Assessment of Anxiety, Depression, Sleep Quality and Quality of Life in Systemic Lupus Erythematosus Patients
NCT05971498 ·Status: UNKNOWN
-
Direct to Patient Minimal Risk Biospecimen and Data Collection Research
NCT07128966 ·Status: RECRUITING
-
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
NCT05000216 ·Status: TERMINATED ·Phase: PHASE2
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
Clinical Risk Assessment of Cognitive Function in Systemic Autoimmune Diseases
NCT06029335 ·Status: UNKNOWN
-
The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients
NCT01359826 ·Status: WITHDRAWN ·Phase: PHASE4
-
FolateScan in Autoimmune Disease
NCT00588393 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular Mechanisms Characteristics in Systemic Lupus Erythematous Autoimmune Disease
NCT02270710 ·Status: WITHDRAWN
-
Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus
NCT03142711 ·Status: COMPLETED
-
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
NCT07175285 ·Status: RECRUITING
-
Rheumatology Patient Registry and Biorepository
NCT04402086 ·Status: RECRUITING
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
Activity and Nutrition Trial in Lupus to Energize and Renew
NCT02281513 ·Status: COMPLETED ·Phase: NA
-
A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis
NCT01085097 ·Status: COMPLETED ·Phase: PHASE2
-
Autoimmunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
NCT03254823 ·Status: COMPLETED
-
fMRI Study of Early Brain Injury in Systemic Lupus Erythematosus
NCT06226324 ·Status: RECRUITING
-
Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
NCT05251415 ·Status: RECRUITING
-
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases
NCT04276701 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Acceptability and Persistence of the Use of a Patient-centred E-health Tool for Lupus Patients Followed in a Specialised Centre in France
NCT03953690 ·Status: TERMINATED
-
Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study
NCT00271934 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis
NCT00594932 ·Status: COMPLETED ·Phase: PHASE1/PHASE2